BeStock  
Stocks › Biotechnology › CGEM

Cullinan Therapeutics CGEM

US equityMarket cap rank #3236Biotechnology
$15.63 −$0.62 (-3.82%)
Pre-market · Oct 8, 8:20 am ET · After hours $15.63 0.00%
Open$15.95
Prev close$16.25
Day range$15.47 – $16.46
Volume808.2K
Market cap$1.01B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership112.3%-1.63 pts vs. prior quarter
Institutions holding220-2 vs. prior quarter
Insider trades (recent)19 buys / 31 sellsNet selling
Short interest14.96% of floatDays to cover 10.9 · as of 15 Sep 2026
Short-sale volume share26.9%5-day average of daily volume

Short-sale volume as % of daily volume

19%24%30%35%Sep '26Sep '26Oct '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$475.8K (8 inflow days, 12 outflow days).

Net flow by order size, last 20 sessions

+$834.2KSuper−$358.4KBig−$5.6MMid−$7.0MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 52.1% of shares outstanding.

Largest holders

  • MPM BioImpact LLC15.12%
  • Lynx1 Capital Management LP13.93%
  • BVF Partners L.P.8.94%
  • BlackRock8.13%
  • T. Rowe Price Group, Inc.5.95%
  • State Street Global Advisors5.70%
  • Kynam Capital Management, LP4.84%
  • Vanguard Capital Management, LLC4.63%

By investor type

  • Mutual Fund54.57%
  • Hedge Fund27.05%
  • VC/PE Fund24.38%
  • Public Company3.74%
  • Individual/Insider1.22%
  • Family Office/Trust0.97%
  • Insurance Company0.72%
  • Private Company0.71%

Reported short interest has fallen from 17.24% to 14.96% of float over the last 6 biweekly reports (30 Jun 2026 to 15 Sep 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
MPM BioImpact LLC VC/PE Fund 2026/Q3 +2,083,073 15.1%
T. Rowe Price Group, Inc. Mutual Fund 2026/Q3 +1,796,231 5.9%
State Street Global Advisors Mutual Fund 2026/Q3 +1,124,512 5.7%
BlackRock Mutual Fund 2026/Q3 +782,800 8.1%
Boone Capital Management LLC Hedge Fund 2026/Q3 +704,442 1.1%
Artal Group S.A. VC/PE Fund 2026/Q3 +700,000 2.9%
RTW Investments, LP Hedge Fund 2026/Q3 +658,387 3.7%
The Goldman Sachs Group, Inc. Public Company 2026/Q3 +536,382 1.5%
Perceptive Advisors LLC VC/PE Fund 2026/Q3 +426,478 0.7%
Adage Capital Management, L.P. Hedge Fund 2026/Q3 +238,000 0.4%
FMR Mutual Fund 2026/Q3 +232,980 0.4%
AQR Capital Management Hedge Fund 2026/Q3 +219,436 0.9%
Vanguard Portfolio Management, LLC Mutual Fund 2026/Q3 +186,188 1.1%
Geode Capital Management, LLC Mutual Fund 2026/Q3 +179,041 2.4%
Squarepoint OPS LLC Hedge Fund 2026/Q3 +168,117 0.3%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
7 Sep 2026 Jennifer Michaelson Chief Scientific Officer Automatic Disposition -4,000 $21.57 158,844
7 Sep 2026 Jennifer Michaelson Chief Scientific Officer Derivative Exercise and Sale -4,000 $21.57 158,844
12 Aug 2026 Jennifer Michaelson Chief Scientific Officer Derivative Exercise and Sale -30,000 $20.26 162,844
5 Jul 2026 Jennifer Michaelson Chief Scientific Officer Automatic Disposition -4,000 $17.82 162,844
5 Jul 2026 Jennifer Michaelson Chief Scientific Officer Derivative Exercise and Sale -4,000 $17.82 162,844
29 Jun 2026 Mary Fenton Chief Financial Officer Other Acquisition +1,541 $8.60 127,921
29 Jun 2026 Jacquelyn Sumer Chief Legal Officer, Chief Compliance Officer & Corporate Secretary Other Acquisition +2,470 $8.60 60,226
15 Jun 2026 Stephen Webster Independent Director Other Derivative Acquisition +25,319 $13.55 25,319
15 Jun 2026 Anthony Rosenberg Independent Chairperson Other Derivative Acquisition +25,319 $13.55 25,319
15 Jun 2026 Mary Thistle Director Other Derivative Acquisition +25,319 $13.55 25,319
15 Jun 2026 Andrew Allen Director Other Derivative Acquisition +21,781 $13.55 21,781
15 Jun 2026 David Meek Independent Director Other Derivative Acquisition +25,319 $13.55 25,319
15 Jun 2026 Mittie Doyle Director Other Derivative Acquisition +21,781 $13.55 21,781
4 May 2026 Jennifer Michaelson Chief Scientific Officer Automatic Disposition -4,000 $15.58 166,844
4 May 2026 Jennifer Michaelson Chief Scientific Officer Derivative Exercise and Sale -4,000 $14.60 166,844
4 Mar 2026 Jennifer Michaelson Chief Scientific Officer Automatic Disposition -4,000 $15.68 170,844
4 Mar 2026 Jennifer Michaelson Chief Scientific Officer Derivative Exercise and Sale -4,000 $15.68 170,844
24 Feb 2026 Jennifer Michaelson Chief Scientific Officer Automatic Disposition -1,780 $14.14 174,844
23 Feb 2026 Jeffrey Jones Chief Medical Officer Open Market Disposition -4,582 $14.47 64,968
23 Feb 2026 Nadim Ahmed Chief Executive Officer Open Market Disposition -13,515 $14.47 148,553

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
15 Sep 2026 9,629,017 15.0% 10.9
31 Aug 2026 10,371,763 16.1% 15.5
14 Aug 2026 10,588,430 16.5% 15.5
31 Jul 2026 10,254,541 16.7% 19.2
15 Jul 2026 10,285,963 16.7% 15.2
30 Jun 2026 10,597,500 17.2% 6.6

Discussion

No comments yet — be the first to weigh in on CGEM.

Leave a comment

Scroll to Top